Close

Eli Lilly & Co. (LLY), BioNTech Enter Immunotherapy Research Collaboration; Lilly to Make Investment

May 11, 2015 3:18 PM EDT Send to a Friend
Eli Lilly & Co. (NYSE: LLY) and BioNTech AG announced they have entered into a research collaboration to discover novel ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login